Advanced Glycation End Products-driven Angiogenesis in Vitro

This publication has 47 references indexed in Scilit:

• Advanced glycosylation end products stimulate the growth but inhibit the prostacyclin‐producing ability of endothelial cells through interactions with their receptors
  FEBS Letters, 1996
• N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins
  Biochemistry, 1995
• Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability
  FEBS Letters, 1995
• Receptor-Mediated Toxicity to Pericytes of Advanced Glycosylation End Products: A Possible Mechanism of Pericyte Loss in Diabetic Microangiopathy
  Biochemical and Biophysical Research Communications, 1995
• Endothelin-1 Mediates Endothelial Cell-Dependent Proliferation of Vascular Pericytes
  Biochemical and Biophysical Research Communications, 1993
• Vascular Pericytes Not Only Regulate Growth, but Also Preserve Prostacyclin-Producing Ability and Protect Against Lipid Peroxide-Induced Injury of Cocultured Endothelial Cells
  Biochemical and Biophysical Research Communications, 1993
• Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
  Biochemical and Biophysical Research Communications, 1992
• Production and characterization of antibodies to advanced glycation products on proteins
  Biochemical and Biophysical Research Communications, 1989
• Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
  New England Journal of Medicine, 1988
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976